skip to main content

Identification of CCNA2 as a Therapeutic Target in Cholangiocarcinoma and Evaluation of Indonesian Jamu-Derived Phytochemicals through Network Pharmacology and Molecular Docking

1Department of Chemistry, Faculty of Mathematics and Natural Science, Universitas Palangka Raya, Palangka Raya, Indonesia

2Faculty of Medicine, Universitas Palangka Raya, Palangka Raya, Indonesia

Received: 5 Jun 2026; Revised: 7 Aug 2026; Accepted: 19 Aug 2026; Published: 30 Sep 2026.
Open Access Copyright 2026 Jurnal Kimia Sains dan Aplikasi under http://creativecommons.org/licenses/by-sa/4.0.

Citation Format:
Cover Image
Abstract

Cholangiocarcinoma (CCA) remains a highly aggressive malignancy with limited therapeutic options and poor prognosis, particularly in Southeast Asia, including Indonesia. The identification of novel molecular targets is essential to improve treatment strategies. This study aimed to identify key therapeutic targets in CCA and evaluate the potential of Indonesian jamu-derived phytochemicals as candidate inhibitors using an integrated computational approach. Differentially expressed genes (DEGs) associated with CCA were analyzed and intersected with disease-related datasets to construct a protein–protein interaction (PPI) network, from which hub genes were identified. Among these, CCNA2, a critical regulator of cell cycle progression, was selected as the primary target due to its central role in tumor proliferation and strong network connectivity. Subsequently, selected phytochemicals derived from Indonesian medicinal plants commonly used in jamu, including Curcuma longa, Curcuma xanthorrhiza, Zingiber officinale, and Kaempferia galanga, were screened for ethnobotanical relevance, their reported anticancer activities in modulating cell cycle progression, and drug-likeness using Lipinski’s rule of five. Molecular docking analysis was performed to evaluate the binding affinity of these compounds against CCNA2. Several phytochemicals demonstrated favorable binding energies comparable to or exceeding that of the native ligand (−8.8 kcal/mol), indicating strong interaction potential within the active site of the protein. The binding interactions were stabilized through hydrogen bonding, hydrophobic interactions, and π- related interactions, suggesting a plausible mechanism for inhibitory activity. This study highlights CCNA2 as a promising therapeutic target in CCA and demonstrates the potential of Indonesian jamu phytochemicals as candidate inhibitors. These findings provide a scientific basis for further experimental validation and support the integration of traditional herbal medicine into modern drug discovery pipelines for cholangiocarcinoma treatment.

Keywords: Cholangiocarcinoma; CCNA2; Jamu; Network Pharmacology

Article Metrics:

  1. Baiq Sheila Okthalia Hakim, Fadila Rahmawati, Alana Akmal Yuar, Febi Jian Setiasari, Nafisya Ayu Evana, Moh Rizky Yolanda B. S., Diagnosis and Management of Cholangiocarcinoma (CCA), Jurnal Biologi Tropis, 25, 4, (2025), 4810-4820 https://doi.org/10.29303/jbt.v25i4.10162
  2. Nittaya Chamadol, Vallop Laopaiboon, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Poowanai Sarkhampee, Winai Ungpinitpong, Phummarat Khamvijite, Yutthapong Chumnanua, Nipath Nethuwakul, Passakorn Sodarat, Samrit Thammarit, Anchalee Techasen, Jaruwan Thuanman, Chaiwat Tawarungruang, Bandit Thinkhamrop, Prakasit Sa-Ngiamwibool, Watcharin Loilome, Piya Prajumwongs, Attapol Titapun, Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts, Heliyon, 10, 18, (2024), e38191 https://doi.org/10.1016/j.heliyon.2024.e38191
  3. Xuan Li, Renchu Guan, Shuangquan Zhang, Factors Contributing to the High Malignancy Level of Cholangiocarcinoma and Its Epidemiology: Literature Review and Data, Biology, 14, 4, (2025), 351 https://doi.org/10.3390/biology14040351
  4. Chaiwat Tawarungruang, Narong Khuntikeo, Nittaya Chamadol, Vallop Laopaiboon, Jaruwan Thuanman, Kavin Thinkhamrop, Matthew Kelly, Bandit Thinkhamrop, Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification, BMC Cancer, 21, (2021), 497 https://doi.org/10.1186/s12885-021-08247-z
  5. Thomas Hughes, Thomas O'Connor, Anchalee Techasen, Nisana Namwat, Watcharin Loilome, Ross H. Andrews, Narong Khuntikeo, Puangrat Yongvanit, Paiboon Sithithaworn, Simon D. Taylor-Robinson, Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem, International Journal of General Medicine, 10, (2017), 227-237 https://doi.org/10.2147/IJGM.S133292
  6. Qingliang Jiang, Xianglin Liu, Weichen Yu, Yangyang Li, Jiaqi Du, Xiaoqing Jiang, Hengyu Li, Integrated analysis reveals survival-related genes promoting cholangiocarcinoma progression via G2/M cell cycle, with validation of cyclin B1 in tumor proliferation, Scientific Reports, 15, (2025), 41352 https://doi.org/10.1038/s41598-025-25299-4
  7. P. Menapree, N. Duangthim, A. Sae-Fung, S. Sonkaew, S. Jitkaew, CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells, Scientific Reports, 15, (2025), 6826 https://doi.org/10.1038/s41598-025-90997-y
  8. Tiza W. Mawaddah, Elisa D. Pratiwi, Astria N. Nidom, Jonny Jonny, Z. I. Ayyuba, I. Y. Rosytania, S. Indrasari, R. V. Nidon, C. A. Nidom, Towards Rigorous Safety Standards for Indonesian Jamu: A Review and Rationale for Non-Human Primate Toxicology Models, Advances in Animal and Veterinary Sciences, 14, 2, (2026), 342-355 https://doi.org/10.17582/journal.aavs/2026/14.2.342.355
  9. Waras Nurcholis, Rini Arianti, Jamu as Indonesian Cultural Heritage and Modern Health Innovation, Jurnal Jamu Indonesia, 9, 1, (2024), 1-2 https://doi.org/10.29244/jji.v9i1.317
  10. Maima Matin, Rajeev K. Singla, Artur Jóźwik, Jarosław Olav Horbańczuk, Natalia Ksepka, Kamil Wysocki, Thadiyan Parambil Ijinu, Neenthamadathil Mohandas Krishnakumar, Sreejith Pongillyathundiyil Sasidharan, Ifeoma C. Ezenyi, John Igoli, Fabio Fusi, Sara Frazzini, Luciana Rossi, Michel-Edwar Mickael, Abhishek Joshi, Olga Adamska, Artur Stolarczyk, Esra Capanoglu, Deniz Gunal-Koroglu, Shi-Hui Cheng, Omar M. Atrooz, Kiran Kharat, Ibrahim M. Abu-Reidah, Neeraj Rani, Atul Kabra, Ruchika Kabra, Dama Sreedhar Preethidan, Prathyusha Surendran, Emad Mohamed Abdallah, Seetha Harilal, Rajesh Kumar, Syed Abidullah, Hemanth Kumar Boyina, Vimal Arora, Prasanna Srinivasan Ramalingam, Sujatha Elangovan, Sivakumar Arumugam, Tanveer Alam, Edlira Aruci, Elena González-Burgos, Isabel Ureña-Vacas, Visitación López-Miranda, Esperanza Herradón, Rupesh Kumar Gautam, Rajat Goyal, Shah Alam Khan, Logesh Rajan, Joel Ojogbane Onoja, Sharad Vats, Akinleye Akinrinde, Smith B. Babiaka, Conrad V. Simoben, Doris E. Enow, Kennedy O. Abuga, Priti Talwar, Palaniyandi Ravanan, Reda El Boukhari, Ahmed Fatimi, Fabien Schultz, Ren-You Gan, Jean Noël Nyemb, Gaetan Bayiha Ba Njock, Constant Anatole Pieme, Goh Goh Bey Hing, Ricardo Lagoa, Nikolay T. Tzvetkov, Farhan Bin Matin, Antonello Santini, Jaya Arora, Aswathy Chankaramkandath Vasu, Suraj Kadunganattil, Abeer Essam Noman, Luay M. Alsubhi, Indra Lasmana Tarigan, Shafaat Yar Khan, Ali Zarrabi, Hefa Mangzira Kemung, Kavitha Raj Varadaraju, Tomasz M. Karpiński, Md. Mohaiminul Islam, Shaikh Jamal Uddin, Carmela Fimognari, Hari Prasad Devkota, Ivana Carev, Dongdong Wang, Kenneth Anchang Yongabi, Luther Bob Mbeku, Sohini Chakraborty, Sourav S. Patnaik, Shanmugam Thangapandiyan, Bikash Baral, Siva Sai Chandragiri, Eliana B. Souto, Gérard Lizard, Fatiha Brahmi, Farid Khallouki, Adil El Midaoui, Ronan Lordan, Anupam Bishayee, Meng-Yao Li, Monika Szymańska-Czerwińska, Krzysztof Niemczuk, Manik Chandra Shill, Michał Ławiński, Oleh Lushchak, Iwona Wojtasik-Kalinowska, Agnieszka Wierzbicka, Thomas Jakschitz, Mathew Dan, Imen Ghzaiel, Leila Rezig, Anne Vejux, Amira Zarrouk, Ahmad Ali, Andy Wai Kan Yeung, Günther K. Bonn, Bairong Shen, Atanas G. Atanasov, Health-promoting and medicinal properties of Zingiberaceae family plants: A minireview with a special focus on galangal, turmeric, cardamom, and ginger, Current Research in Biotechnology, 10, (2025), 100329 https://doi.org/10.1016/j.crbiot.2025.100329
  11. Sirinya Moakmamern, Lapamas Rueankham, Natsima Viriyaadhammaa, Wenxian Yin, Toyonobu Usuki, Suwit Duangmano, Yupanun Wutti-In, Sawitree Chiampanichayakul, Nutjeera Intasai, Siriporn Okonogi, Singkome Tima, Songyot Anuchapreeda, 6-Shogaol from Zingiber officinale Induces Cell Cycle Arrest via Suppression of c-Myc Protein Expression and Promotes Apoptosis in Human B-Cell Lymphoma, International Journal of Molecular Sciences, 27, 10, (2026), 4168 https://doi.org/10.3390/ijms27104168
  12. W. Park, A. R. M. R. Amin, Z. G. Chen, D. M. Shin, New Perspectives of Curcumin in Cancer Prevention, Cancer Prevention Research, 6, 5, (2013), 387-400 https://doi.org/10.1158/1940-6207.CAPR-12-0410
  13. A. Simamora, K. H. Timotius, M. B. Yerer, H. Setiawan, A. Mun'im, Xanthorrhizol, a potential anticancer agent, from Curcuma xanthorrhiza Roxb, Phytomedicine, 105, (2022), 154359 https://doi.org/10.1016/j.phymed.2022.154359
  14. Yingzi Wu, Jinhai Luo, Baojun Xu, Insights into the anticancer effects of galangal and galangin: A comprehensive review, Phytomedicine, 135, (2024), 156085 https://doi.org/10.1016/j.phymed.2024.156085
  15. S. Hu, Y. Xu, L. Meng, L. Huang, H. Sun, Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells, Experimental and Therapeutic Medicine, 16, 2, (2018), 1266-1272 https://doi.org/10.3892/etm.2018.6345
  16. Nathan M. Weir, Karuppaiyah Selvendiran, Vijay Kumar Kutala, Liyue Tong, Shilpa Vishwanath, Murugesan Rajaram, Susheela Tridandapani, Shrikant Anant, Periannan Kuppusamy, Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK, Cancer Biology & Therapy, 6, 2, (2007), 178-184 https://doi.org/10.4161/cbt.6.2.3577
  17. Mahmoud Hashemzaei, Amin Delarami Far, Arezoo Yari, Reza Entezari Heravi, Kaveh Tabrizian, Seyed Mohammad Taghdisi, Sarvenaz Ekhtiari Sadegh, Konstantinos Tsarouhas, Dimitrios Kouretas, George Tzanakakis, Dragana Nikitovic, Nikita Yurevich Anisimov, Demetrios A. Spandidos, Aristides M. Tsatsakis, Ramin Rezaee, Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo, Oncology Reports, 38, 2, (2017), 819-828 https://doi.org/10.3892/or.2017.5766
  18. Ahmad Almatroudi, Khaled S. Allemailem, Wanian M. Alwanian, Basmah F. Alharbi, Faris Alrumaihi, Amjad Ali Khan, Saleh A. Almatroodi, Arshad Husain Rahmani, Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways, International Journal of Molecular Sciences, 24, 10, (2023), 8630 https://doi.org/10.3390/ijms24108630
  19. Kuan-Beng Ng, Ahmad Bustamam, Mohd Aspollah Sukari, Siddig Ibrahim Abdelwahab, Syam Mohan, Michael James Christopher Buckle, Behnam Kamalidehghan, Nabilah Muhammad Nadzri, Theebaa Anasamy, A Hamid A Hadi, Heshu Sulaiman Rahman, Induction of selective cytotoxicity and apoptosis in human T4-lymphoblastoid cell line (CEMss) by boesenbergin a isolated from boesenbergia rotunda rhizomes involves mitochondrial pathway, activation of caspase 3 and G2/M phase cell cycle arrest, BMC Complementary and Alternative Medicine, 13, (2013), 41 https://doi.org/10.1186/1472-6882-13-41
  20. Douglas Hanahan, Hallmarks of Cancer: New Dimensions, Cancer Discovery, 12, 1, (2022), 31-46 https://doi.org/10.1158/2159-8290.CD-21-1059
  21. Giammarco Fava, Molecular mechanisms of cholangiocarcinoma, World Journal of Gastrointestinal Pathophysiology, 1, 1, (2010), 12-22 https://doi.org/10.4291/wjgp.v1.i1.12
  22. Özgür Cem Erkin, Betül Cömertpay, Esra Göv, Integrative Analysis for Identification of Therapeutic Targets and Prognostic Signatures in Non-Small Cell Lung Cancer, Bioinformatics and Biology Insights, 16, (2022), https://doi.org/10.1177/11779322221088796
  23. P. Łukasik, M. Załuski, I. Gutowska, Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review, International Journal of Molecular Sciences, 22, 6, (2021), 2935 https://doi.org/10.3390/ijms22062935
  24. Tingting Shen, Lei Sheng, Hua Zhan, Sihan Chen, The analysis of TOP2A as a potential target for predicting the prognosis of brain glioma in the TCGA database and in single-center study, Discover Oncology, 16, (2025), 2291 https://doi.org/10.1007/s12672-025-04051-4
  25. Rand Shahin, Salah Aljamal, Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies, Future Science OA, 8, 3, (2022), FSO778 https://doi.org/10.2144/fsoa-2021-0116
  26. Alphonse E. Sirica, Gregory J. Gores, John D. Groopman, Florin M. Selaru, Mario Strazzabosco, Xin Wei Wang, Andrew X. Zhu, Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances, Hepatology, 69, 4, (2019), 1803-1815 https://doi.org/10.1002/hep.30289
  27. The Gene Ontology Consortium, The Gene Ontology knowledgebase in 2026, Nucleic Acids Research, 54, D1, (2026), D1779-D1792 https://doi.org/10.1093/nar/gkaf1292
  28. Xiwei Ding, Tianlu Huang, Chunyan Peng, Keun Soo Ahn, Jesper B. Andersen, Monika Lewinska, Yu Cao, Guifang Xu, Gang Chen, Bo Kong, Helmut Friess, Shanshan Shen, Lewis R. Roberts, Lei Wang, Xiaoping Zou, Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in Cholangiocarcinoma, Journal of Cancer, 11, 8, (2020), 2241-2251 https://doi.org/10.7150/jca.31989
  29. Minako Yamamura, Yasunori Sato, Kenta Takahashi, Motoko Sasaki, Kenichi Harada, The cyclin-dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma, Oncology Reports, 43, 1, (2019), 306-317 https://doi.org/10.3892/or.2019.7405
  30. O. I. Kahn, N. Ha, M. A. Baird, M. W. Davidson, P. W. Baas, TPX 2 regulates neuronal morphology through kinesin‐5 interaction, Cytoskeleton, 72, 7, (2015), 340-348 https://doi.org/10.1002/cm.21234
  31. W. Gao, J. Lu, Z. Yang, E. Li, Y. Cao, L. Xie, Mitotic Functions and Characters of KIF11 in Cancers, Biomolecules, 14, 4, (2024), 386 https://doi.org/10.3390/biom14040386
  32. J. Stumpff, P. N. Ghule, A. Shimamura, J. L. Stein, M. Greenblatt, Spindle Microtubule Dysfunction and Cancer Predisposition, Journal of Cellular Physiology, 229, 12, (2014), 1881-1883 https://doi.org/10.1002/jcp.24691
  33. P. J. Smith, S. R. McKeown, L. H. Patterson, Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (UHAPS), IUBMB Life, 75, 1, (2023), 40-54 https://doi.org/10.1002/iub.2619
  34. K. Maemura, S. Natsugoe, S. Takao, Molecular mechanism of cholangiocarcinoma carcinogenesis, Journal of Hepato-Biliary-Pancreatic Sciences, 21, 10, (2014), 754-760 https://doi.org/10.1002/jhbp.126
  35. Zhixiang Wang, Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling, Cells, 10, 12, (2021), 3327 https://doi.org/10.3390/cells10123327
  36. Jing Liu, Yunhua Peng, Wenyi Wei, Cell cycle on the crossroad of tumorigenesis and cancer therapy, Trends in Cell Biology, 32, 1, (2022), 30-44 https://doi.org/10.1016/j.tcb.2021.07.001
  37. Yuichiro Hatano, Takayasu Ideta, Akihiro Hirata, Kayoko Hatano, Hiroyuki Tomita, Hideshi Okada, Masahito Shimizu, Takuji Tanaka, Akira Hara, Virus-Driven Carcinogenesis, Cancers, 13, 11, (2021), 2625 https://doi.org/10.3390/cancers13112625
  38. J. Charostad, M. Nakhaie, A. Dehghani, E. Faghihloo, The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis, Infectious Agents and Cancer, 15, (2020), 62 https://doi.org/10.1186/s13027-020-00317-4
  39. H. K. Matthews, C. Bertoli, R. A. M. De Bruin, Cell cycle control in cancer, Nature Reviews Molecular Cell Biology, 23, (2022), 74-88 https://doi.org/10.1038/s41580-021-00404-3
  40. C. H. Chin, S. H. Chen, H. H. Wu, C. W. Ho, M. T. Ko, C. Y. Lin, cytoHubba: identifying hub objects and sub-networks from complex interactome, BMC Systems Biology, 8, (2014), S11 https://doi.org/10.1186/1752-0509-8-S4-S11
  41. A. L. Barabási, N. Gulbahce, J. Loscalzo, Network medicine: a network-based approach to human disease, Nature Reviews Genetics, 12, (2011), 56-68 https://doi.org/10.1038/nrg2918
  42. Cheerapinya Taebprakhon, Supannika Sorin, Kullanat Khawkhiaw, Chatchai Phoomak, Wunchana Seubwai, Sopit Wongkham, Charupong Saengboonmee, Pro-Tumorigenic Roles of Cyclin Dependent Kinase 2 and its Associated Cyclins in Cholangiocarcinoma Progression under High Glucose Condition, Archives of Medical Research, 57, 3, (2026), 103383 https://doi.org/10.1016/j.arcmed.2026.103383
  43. Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, Ilenia Segatto, Valentina Rossi, Nicole Crestan, Javad Karimbayli, Barbara Belletti, Gustavo Baldassarre, Cyclin-dependent protein kinases and cell cycle regulation in biology and disease, Signal Transduction and Targeted Therapy, 10, (2025), 11 https://doi.org/10.1038/s41392-024-02080-z
  44. Hiroyuki Yamano, APC/C: current understanding and future perspectives, F1000Research, 8, (2019), 725 https://doi.org/10.12688/f1000research.18582.1
  45. D. Ramírez, J. Caballero, Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?, Molecules, 23, 5, (2018), 1038 https://doi.org/10.3390/molecules23051038
  46. Ibrahim Jantan, Fadlina Chany Saputri, Muhammad Naeem Qaisar, Fhataheya Buang, Correlation between Chemical Composition of Curcuma domestica and Curcuma xanthorrhiza and Their Antioxidant Effect on Human Low-Density Lipoprotein Oxidation, Evidence-Based Complementary and Alternative Medicine, 2012, (2012), 438356 https://doi.org/10.1155/2012/438356
  47. Romy Jon Hendra, Rusdi Rusdi, Ridho Asra, Sestry Misfadhila, Phytochemical and Traditional Uses of Red Ginger: A Review (Zingiber officinale var. rubrum), EAS Journal of Pharmacy and Pharmacology, 4, 3, (2022), 50-55 https://doi.org/10.36349/easjpp.2022.v04i03.002
  48. Swarupananda Mukjerjee, Dipanjan Karati, A mechanistic view on phytochemistry, pharmacognostic properties, and pharmacological activities of phytocompounds present in Zingiber officinale: A comprehensive review, Pharmacological Research - Modern Chinese Medicine, 5, (2022), 100173 https://doi.org/10.1016/j.prmcm.2022.100173
  49. Nataya Sutthanont, Wej Choochote, Benjawan Tuetun, Anuluck Junkum, Atchariya Jitpakdi, Udom Chaithong, Doungrat Riyong, Benjawan Pitasawat, Chemical composition and larvicidal activity of edible plant-derived essential oils against the pyrethroid-susceptible and -resistant strains of Aedes aegypti (Diptera: Culicidae), Journal of Vector Ecology, 35, 1, (2010), 106-115 https://doi.org/10.1111/j.1948-7134.2010.00066.x
  50. Tanat Na Nongkhai, Sarah E. Maddocks, Santi Phosri, Sarita Sangthong, Punyawatt Pintathong, Phanuphong Chaiwut, Kasemsiri Chandarajoti, Lutfun Nahar, Satyajit D. Sarker, Tinnakorn Theansungnoen, In Vitro Cytotoxicity and Antimicrobial Activity against Acne-Causing Bacteria and Phytochemical Analysis of Galangal (Alpinia galanga) and Bitter Ginger (Zingiber zerumbet) Extracts, International Journal of Molecular Sciences, 25, 20, (2024), 10869 https://doi.org/10.3390/ijms252010869
  51. Muhammad Ramzan, Basit Zeshan, Assessment of the Phytochemical Analysis and Antimicrobial Potentials of Zingiber zerumbet, Molecules, 28, 1, (2023), 409 https://doi.org/10.3390/molecules28010409
  52. Agus Chahyadi, Rika Hartati, Komar Ruslan Wirasutisna, Elfahmi Elfahmi, Boesenbergia Pandurata Roxb., An Indonesian Medicinal Plant: Phytochemistry, Biological Activity, Plant Biotechnology, Procedia Chemistry, 13, (2014), 13-37 https://doi.org/10.1016/j.proche.2014.12.003
  53. A. P. Widiyana, S. Herlina, R. Risadiansyah, G. Ashari, Major Phytochemicals of Boesenbergia pandurata Rhizome by LC-HRMS and Virtual Screening of Staphylococcus aureus Inhibition, The 1st International Conference on Biological Technology and Engineering for Sustainable Nature (IC-BioTEStA 2025), 2026 https://doi.org/10.1051/bioconf/202620903008
  54. Daniel F. Veber, Stephen R. Johnson, Hung-Yuan Cheng, Brian R. Smith, Keith W. Ward, Kenneth D. Kopple, Molecular Properties That Influence the Oral Bioavailability of Drug Candidates, Journal of Medicinal Chemistry, 45, 12, (2002), 2615-2623 https://doi.org/10.1021/jm020017n
  55. Deliang Chen, Numan Oezguen, Petri Urvil, Colin Ferguson, Sara M. Dann, Tor C. Savidge, Regulation of protein-ligand binding affinity by hydrogen bond pairing, Science Advances, 2, 3, (2016), e1501240 https://doi.org/10.1126/sciadv.1501240
  56. R. Ferreira De Freitas, M. Schapira, A systematic analysis of atomic protein–ligand interactions in the PDB, Medicinal Chemistry Communications, 8, 10, (2017), 1970-1981 https://doi.org/10.1039/C7MD00381A
  57. Esteban Lanzarotti, Rolf R. Biekofsky, Darío A. Estrin, Marcelo A. Marti, Adrián G. Turjanski, Aromatic–Aromatic Interactions in Proteins: Beyond the Dimer, Journal of Chemical Information and Modeling, 51, 7, (2011), 1623-1633 https://doi.org/10.1021/ci200062e
  58. R. Patil, S. Das, A. Stanley, L. Yadav, A. Sudhakar, A. K. Varma, Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing, PLoS ONE, 5, 8, (2010), e12029 https://doi.org/10.1371/journal.pone.0012029
  59. Enrico Di Cera, Mechanisms of ligand binding, Biophysics Reviews, 1, (2020), 011303 https://doi.org/10.1063/5.0020997
  60. A. F. A. Hidayat, S. B. Mohamad, Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis, Journal of Visualized Experiments, 220, (2025), 67174 https://doi.org/10.3791/67174
  61. J. Kubiak, P. Szyk, B. Czarczynska-Goslinska, T. Goslinski, Flavonoids, Chalcones, and Their Fluorinated Derivatives—Recent Advances in Synthesis and Potential Medical Applications, Molecules, 30, 11, (2025), 2395 https://doi.org/10.3390/molecules30112395
  62. Y. Gan, Y. Li, T. Li, G. Shu, G. Yin, CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer, Cancer Management and Research, 10, (2018), 5113-5124 https://doi.org/10.2147/CMAR.S176833
  63. Qing Wan, Zhongmin Yang, Lian Huang, Yang Xia, Lihua Long, Zucai Xu, Jida Li, Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies, Molecular Biomedicine, 7, (2026), 14 https://doi.org/10.1186/s43556-026-00411-w

Last update:

No citation recorded.

Last update: 2026-10-08 14:19:57

No citation recorded.